In this video


Kodak CEO: We need to have these pharmaceuticals here, we need to protect our people

Kodak Executive Chairman and CEO James Continenza discussed an agreement his company signed with the federal government for a $765 million loan to develop generic drug ingredients for Covid-19 treatments.
Wed, Jul 29 20203:20 PM EDT